Imatinib D4 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
Molecular Weight:
497.63
CAS Number:
[1134803-16-9]
Formula:
C29H31N7O
Target:
PDGFR|||Autophagy|||c-Kit|||SARS-CoV|||Bcr-Abl
T11639
* VAT and and shipping costs not included. Errors and price changes excepted